| 000 | 01558 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250515040333.0 | ||
| 264 | 0 | _c20061218 | |
| 008 | 200612s 0 0 eng d | ||
| 022 | _a0959-8049 | ||
| 024 | 7 |
_a10.1016/j.ejca.2006.06.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSalzberg, Marc | |
| 245 | 0 | 0 |
_aTrastuzumab (Herceptin) in patients with HER-2-overexpressing metastatic or locally advanced transitional cell carcinoma of the bladder: report on 7 patients. _h[electronic resource] |
| 260 |
_bEuropean journal of cancer (Oxford, England : 1990) _cOct 2006 |
||
| 300 |
_a2660-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarcinoma, Transitional Cell _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xmetabolism |
| 650 | 0 | 4 |
_aReceptor, ErbB-2 _xmetabolism |
| 650 | 0 | 4 | _aTrastuzumab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aBorner, Markus | |
| 700 | 1 | _aBauer, Jean-Alexandre | |
| 700 | 1 | _aMorant, Rudolf | |
| 700 | 1 | _aRauch, Daniel | |
| 700 | 1 | _aRochlitz, Christoph | |
| 773 | 0 |
_tEuropean journal of cancer (Oxford, England : 1990) _gvol. 42 _gno. 15 _gp. 2660-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejca.2006.06.009 _zAvailable from publisher's website |
| 999 |
_c16520711 _d16520711 |
||